Home / Pharma Healthcare / Genome Editing - Global Market Outlook (2016-2022)

Genome Editing - Global Market Outlook (2016-2022)

  • Id : RNR-54106
  • Category : Pharma Healthcare
  • Publish Date : Oct 2016
  • Pages : 0
  • Publisher : Stratistics MRC
License Type

According to Stratistics MRC, the Global Genome Editing market is estimated at $2098.9 million in 2015 and is expected to reach $5367.64 million by 2022 growing at a CAGR of 14.3% from 2015 to 2022. Increasing investment and more focus  on research and development by companies for new treatment are the key factors driving the market growth. Strict rules imposed by governments across the regions is restraining genome editing market. Technological advancements generate pool of opportunities for market growth.

North America captured huge market share owing to the increase in biotechnology and pharmaceutical industries in United States. However, Asia Pacific is anticipated to be the fastest growing region with highest CAGR during forecast period, because of rapid increase in research and development this region. Pharmaceutical and Biotechnology Companies in end user segment holds largest share in the market.

Some of the key players in the market are Sangamo Biosciences, Inc., Origene Technologies, Inc., MERCK KGAA, Thermo Fisher Scientific, Inc., New England Biolabs, Inc., CELLECTIS S.A., Horizon Discovery Group Plc, Lonza Group Ltd., APPLIED STEMCELL INC., Sigma-Aldrich Corporation, Transposagen Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc and Genscript USA Inc.

Products And Services Covered:
• Genome Editing Services
• Software
• Reagents, Enzymes and Consumables
o Delivery Tools
o Genome Editing Tools And Kits
o Other Reagents, Enzymes And Consumables
• Instruments
• Cell Lines and Animal Models

Technologies Covered:
• Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9)
o Crispr Dcas9
o Wt Crispr/Cas9
o Crispr/Cas9 Nickase
• Transcription Activator-Like Effector Nucleases (Talen)
• Zinc Finger Nuclease (Zfn)
• Antisense Technology
• Other Technologies
o Arcus (Homing Endonuclease) And Megatal
o Recombinant Adeno-Associated Virus (R Aav)
o Targatt And Rapid Trait Development System (Rtds)
o Piggybac Transposase And Sleeping Beauty Transposon

Applications Covered:
• Plant Biotechnology/Agriculture
• Drug Discovery and Development
o Clinical
o Pre-Clinical
• Basic Research
o Genomic Visualization
o Genomic Screening
o Transcription Activation/Repression
• Animal Biotechnology
o Livestock
o Animal Health
o Other Animal Biotechnology
• Cell Line Engineering

End Users Covered:
• Pharmaceutical And Biotechnology Companies
• Academic And Government Research Institutes
• Plant Biotechnology Companies
• Others End Users
o Contract Research Organizations (Cro)
o Animal Biotechnology

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain  
o Rest of Europe    
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific    
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements